EVIDENT (Ebola) and DECISION (COVID-19 portable PCR platform) both address infectious disease detection in operational settings.
BUNDESMINISTERIUM DER VERTEIDIGUNG
German defence ministry contributing end-user expertise in portable diagnostics and electromagnetic compatibility for dual-use field applications.
Their core work
Germany's Federal Ministry of Defence participates in EU research projects where military and civilian health security intersect. Their H2020 involvement focuses on rapid diagnostics for infectious disease outbreaks (Ebola, COVID-19) and electromagnetic risk management — both areas with clear dual-use relevance for military personnel and first responders. The ministry contributes domain expertise in field-deployable technologies, operational requirements for austere environments, and defense-sector regulatory frameworks rather than conducting laboratory research itself.
What they specialise in
PETER project focuses on electromagnetic interference risk management, directly relevant to defense electronics and communications.
Both EVIDENT (Ebola, 2014) and DECISION (coronavirus, 2020) address epidemic/pandemic preparedness from a defense perspective.
DECISION project specifically targets handheld, battery-powered, portable molecular testing for first responders and home use.
How they've shifted over time
The ministry's early H2020 involvement (2014) centered on the Ebola outbreak response, reflecting immediate crisis-driven participation in health security research. From 2019 onward, their focus shifted to more structured, technology-driven areas: electromagnetic risk management for defense systems (PETER) and miniaturized portable diagnostics platforms (DECISION). This evolution suggests a move from reactive crisis participation toward proactive investment in dual-use field technologies.
Moving toward field-deployable health and sensing technologies with dual civilian-military applications, making them a relevant partner for projects requiring defense-sector end-user validation.
How they like to work
The ministry participates exclusively as a consortium partner, never as coordinator — consistent with its role as an end-user and requirements provider rather than a research performer. With 32 unique partners across just 3 projects, it joins larger consortia (averaging ~11 partners per project), contributing operational perspective and access to defense-sector testing environments. This makes them a valuable but hands-off partner: they bring real-world deployment context but expect others to lead the technical work.
Despite only 3 projects, the ministry has built connections with 32 partners across 10 countries, reflecting participation in broad European consortia. The network spans multiple EU member states with no obvious geographic concentration beyond central Europe.
What sets them apart
As a national defense ministry participating in civilian EU research, this organization offers something few partners can: direct access to military end-user requirements, field testing contexts, and defense procurement pathways. For projects developing portable diagnostics, EMC-compliant devices, or first-responder technologies, the ministry provides validation that the technology meets the demands of austere operational environments. This dual-use bridge between civilian research and defense application is rare in H2020 consortia.
Highlights from their portfolio
- DECISIONLargest funding (EUR 425,250) — developing a miniaturized disposable molecular diagnostics platform for coronavirus, directly addressing COVID-19 pandemic needs with portable, battery-powered PCR technology.
- EVIDENTEarly crisis-response project on Ebola virus disease, addressing correlates of protection and clinical management during the 2014 West Africa outbreak.
- PETERPan-European training network on electromagnetic risk management — unusual for a defense ministry to participate in an MSCA training network, signaling investment in next-generation EMC expertise.